Skip to search formSkip to main contentSkip to account menu

Immediate-release Onapristone

Known as: IR Onapristone 
An immediate-release (IR) formulation of onapristone, an orally bioavailable progesterone receptor (PR) antagonist, with antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract 1646: Synthesis of [11C]onapristone for clinical investigation
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Background: Onapristone is a type I anti-progestin, which… 
2002
2002
Expresión y funcionalidad del receptor de progesterona (RP) en la modulación del crecimiento hormono-dependiente y en la adquisición de resistencia al tratamiento hormonal de un modelo murino de…
El cancer de mama es la segunda causa de muerte en las mujeres, luego del cancer de pulmon. En el desarrollo de esta enfermedad… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)